Presentation TCT 2015 Debate: The Case for Short-term DAPT in Most Patients! Presenter: Gennaro Giustino October 11, 2015 REGISTER for free or LOG IN to view this content Presentation TCT 2015 Up Next Presentation TCT 2015 Stroke and Bleeding Risk Scores: How to Use These in Practice Presenter: Brian K. Whisenant October 11, 2015 More slides + Presentation TCT 2015 Should FFR Be Used Routinely in STEMI Patients With Multivessel Disease, and Is It Reliable During the Index and/or Staged Procedures? Presenter: Colin Berry October 11, 2015 Presentation TCT 2015 Debate 2: Should Long-term (2 Years to Life) Dual Antiplatelet Therapy Be Used in Most Patients After MI? Yes, and the Data Are Strong for Ticagrelor (PEGASUS Trial)! Presenter: Neal S. Kleiman October 11, 2015 We Recommend
Presentation TCT 2015 Stroke and Bleeding Risk Scores: How to Use These in Practice Presenter: Brian K. Whisenant October 11, 2015
Presentation TCT 2015 Should FFR Be Used Routinely in STEMI Patients With Multivessel Disease, and Is It Reliable During the Index and/or Staged Procedures? Presenter: Colin Berry October 11, 2015
Presentation TCT 2015 Debate 2: Should Long-term (2 Years to Life) Dual Antiplatelet Therapy Be Used in Most Patients After MI? Yes, and the Data Are Strong for Ticagrelor (PEGASUS Trial)! Presenter: Neal S. Kleiman October 11, 2015